News and Resources

Joint West Africa Research Group to Foster Biopreparedness

The West African Ebola outbreak highlighted gaps in global public health response and a lack of countermeasures. The DoD invested in a strategic initiative called the Join West Africa Research Group (JWARG) to leverage existing research platforms and relationships to improve biopreparedness in the region. This new program is a…

MHRP, WRAIR Begin New Phase 2 Clinical Trial of Ebola Vaccine Regimens

The Walter Reed Army Institute of Research (WRAIR) today announced the initiation of a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers. This study includes two vaccine candidates, Ad26.ZEBOV from Crucell Holland B.V., one of…

New Ebola vaccine study begins in Nigeria

MHRP began a new Ebola vaccine study last week at its site in Abuja, Nigeria in collaboration with the Nigerian Ministries of Defence and Health. The vaccine used in the study (RV429) is the monovalent chimpanzee adenovirus Type 3 (ChAd3) candidate developed at the NIAID and being developed by GlaxoSmithKline…